BC Extra | Feb 26, 2016
Financial News

HBV newco Chromis gets $3M seed round

HBV play Chromis Therapeutics Inc. (San Diego, Calif.) raised $3 million in seed financing from Torrey Pines Investment . Chromis' lead candidate is CHR101 , a preclinical HBV treatment targeting covalently closed circular DNA (cccDNA). Torrey Pines...
Items per page:
1 - 1 of 1